Vanda Pharmaceuticals
VNDA
$4.80
Share price
3.90%
Change (1 day)
-21.82%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.64 B
According to Vanda Pharmaceuticals's latest financial reports the company's total assets are $0.64 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Vanda Pharmaceuticals - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.64 B | 2.24% |
| 2022-12-31 | $0.63 B | 6.81% |
| 2021-12-31 | $0.59 B | 11.31% |
| 2020-12-31 | $0.53 B | 10.28% |
| 2019-12-31 | $0.48 B | 45.65% |
| 2018-12-31 | $0.33 B | 61.68% |
| 2017-12-31 | $0.20 B | -2.35% |
| 2016-12-31 | $0.21 B | -1.26% |
| 2015-12-31 | $0.21 B | 24.08% |
| 2014-12-31 | $0.17 B | 19.78% |
| 2013-12-31 | $0.14 B | 5.83% |
| 2012-12-31 | $0.13 B | -25.83% |
| 2011-12-31 | $0.18 B | -14.3% |
| 2010-12-31 | $0.21 B | -5.59% |
| 2009-12-31 | $0.22 B | 352.03% |
| 2008-12-31 | $49.93 M | -48.45% |
| 2007-12-31 | $96.86 M | 167.13% |
| 2006-12-31 | $36.26 M | 1.42% |
| 2005-12-31 | $35.75 M | 101.4% |
| 2004-12-31 | $17.75 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 25,740.17% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 14,447.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 34,830.14% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 9,770.81% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 16,351.02% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 15,172.19% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $8.08 M | -98.75% | 🇺🇸 USA |